D.E. Shaw & Co
DMTK

D.E. Shaw & Co’s DermTech, Inc. Common Stock DMTK Stock Holding History

D.E. Shaw & Co’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-69,108
Closed -$121K – 4846
2023
Q4 		$121K Buy
+69,108
New +$101K ﹤0.01% 3950
2023
Q2 		– Sell
-45,715
Closed -$168K – 4689
2023
Q1 		$168K Sell
45,715
-208,585
-82% -$878K ﹤0.01% 3933
2022
Q4 		$450K Buy
+254,300
New +$676K ﹤0.01% 3910
2021
Q2 		– Sell
-17,961
Closed -$738K – 5090
2021
Q1 		$912K Buy
+17,961
New +$939K ﹤0.01% 3188
2019
Q4 		– Sell
-247,500
Closed -$1.39M – 4221
2019
Q3 		$1.39M Buy
+247,500
New +$2.95M ﹤0.01% 2630

Other funds holding DMTK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WIC
Woodmont Investment Counsel Nashville, Tennessee $1.62B AUM 18.92% 1-Year Est. Return

D.E. Shaw & Co's DMTK Position: Q1 2024 in Review

D.E. Shaw & Co sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2024, closing a stake of 69,108 shares — an estimated $121K sold.

D.E. Shaw & Co first reported a position in DMTK in Q3 2019 and held it in 5 quarters. The position peaked at $1.39M in Q3 2019. 69 funds tracked by Wall St. Rank hold DMTK as of Q1 2024.

  • D.E. Shaw & Co reported no remaining DermTech, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 69,108 DermTech, Inc. Common Stock shares in Q1 2024, an estimated $121K.
  • D.E. Shaw & Co first reported a position in DermTech, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
  • D.E. Shaw & Co's DermTech, Inc. Common Stock position peaked at $1.39M in Q3 2019.
  • 69 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.